Showing 231-240 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Autoimmune stem-like T cells in type 1 diabetes Memorial Sloan-Kettering Cancer Center Andrea Schietinger Cures 01-September-2023 to 31-August-2026 $750,000.00
Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Patients Mayo Clinic Adrian Vella Improving Lives 01-October-2019 to 31-March-2025 $437,405.39
Assessment of Beta Cell Small Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes Mayo Clinic Naureen Javeed Cures 01-September-2022 to 31-August-2025 $400,000.00
Optimizing islet cell graft performance with targeted alpha and beta cell composition and distribution Mayo Clinic Quinn Peterson Cures 01-April-2025 to 31-March-2027 $699,138.64
A Nanosensor Embedded Device for Rapid Insulin Measurement Massachusetts Institute of Technology Michael Strano Improving Lives 01-April-2024 to 31-March-2027 $600,000.00
The T1D Parent Check-In: A Preventative Intervention Massachusetts General Hospital Ellen O'Donnell Improving Lives 01-July-2023 to 30-June-2026 $390,792.17
Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D Massachusetts General Hospital Mark Poznansky Cures 01-April-2023 to 31-March-2026 $777,168.00
Demand for Combined CGM-Pump Devices in Type 1 Diabetes Magnolia Innovation, LLC Kenneth Howie Improving Lives 01-August-2025 to 15-February-2026 $291,000.00
T1D Adjunct Therapy Product & Patient Profiling Study Magnolia Innovation, LLC Kenneth Howie Improving Lives 01-December-2024 to 30-September-2025 $434,000.00
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749,995.50